Literature DB >> 26607120

HIV and hepatitis C virus co-infection in Kenya.

Anton Andonov1, Elijah Songok2, Missiani Ochwoto2, Carla Osiowy3, T Blake Ball3.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26607120     DOI： 10.1016/S1473-3099(15)00403-X

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  4 in total

Review 1.  Update in HIV-hepatitis C virus coinfection in the direct acting antiviral era.

Authors:  Eric G Meissner
Journal:  Curr Opin Gastroenterol       Date:  2017-05       Impact factor: 3.287

2.  Prevalence, estimated incidence, risk behaviours, and genotypic distribution of hepatitis C virus among people who inject drugs accessing harm-reduction services in Kenya: a retrospective cohort study.

Authors:  Matthew J Akiyama; Charles M Cleland; John A Lizcano; Peter Cherutich; Ann E Kurth
Journal:  Lancet Infect Dis       Date:  2019-09-17       Impact factor: 25.071

3.  The Prevalence of Hepatitis C Virus Antibody in HIV-Negative Persons in Kenya, 2007.

Authors:  Kathleen N Ly; Andrea A Kim; Jan Drobeniuc; Maja Kodani; Joel M Montgomery; Barry S Fields; Eyasu H Teshale
Journal:  Am J Trop Med Hyg       Date:  2018-04-19       Impact factor: 2.345

4.  Characterization of occult hepatitis B in high-risk populations in Kenya.

Authors:  Kiptoon Beatrice Jepkemei; Missiani Ochwoto; Ken Swidinsky; Jacqueline Day; Henok Gebrebrhan; Lyle R McKinnon; Anton Andonov; Julius Oyugi; Joshua Kimani; George Gachara; Elijah Maritim Songok; Carla Osiowy
Journal:  PLoS One       Date:  2020-05-28       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.